Buy & Sell Bank of New York Mellon Corp (BK) – Bank of New York Mellon Corp Price Today
Aura AI Summary
Key Stats
- $89.57BMarket Cap
- FinancialsSector
- -5.71%3M Drawdown
- -Enterprise Value
- 1.62%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 56 daysTypical Hold Time
Bank of New York Mellon Corp (BK) is currently valued at a market capitalization of $89.57B. Over the past 52 weeks, Bank of New York Mellon Corp has traded between a low of $85.91 and a high of $137.92, highlighting its annual price range. Over the past three months, Bank of New York Mellon Corp has recorded a drawdown of -5.71%, reflecting recent price volatility. Bank of New York Mellon Corp offers a dividend yield of 1.62%, with the most recent dividend of $0.53 paid on 27 Apr 26. On average, investors hold Bank of New York Mellon Corp for approximately 56 days, indicating typical investor behavior on the platform.
About Bank of New York Mellon Corp
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.
Most Recent News
Presbyopia market to grow at 4.9% CAGR by 2036, driven by aging population and new treatments.
The global presbyopia market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2036, fueled by the increasing aging population and rising prevalence of near vision impairment. Market expansion is supported by greater a...

Personalized medicine market to exceed $1 trillion by 2034, driven by genomics and AI advances.
The personalized medicine market is projected to grow from USD 524 billion in 2025 to over USD 1 trillion by 2034, fueled by advances in genomics, biomarker diagnostics, and AI-powered data analytics. This growth is driven by rising chronic diseases ...

New report details Diageo's financials, SWOT, and market position in Food & Beverages industry
ResearchAndMarkets.com released a comprehensive report on Diageo plc covering its financial performance, SWOT analysis, competitive landscape, and industry position. The report highlights Diageo's strengths like its strong brand portfolio and financi...
